Brain injuries are not always easy to recognize. Symptoms such as headaches, brain fog, memory problems, mood changes, trouble sleeping, and difficulty concentrating can have many different causes. That's why healthcare providers often need more than symptoms alone to determine whether a brain injury or neurological disease may be present.
Our neurodiagnostic solutions provide objective biological data, giving your healthcare provider a more complete picture by considering alongside your symptoms, medical history, and other clinical information.
Annual TBI incidence
Adults live with a TBI-related disability
Of adults that sustain a brain injury never receive care
Of standard CT scans return normal results where brain injury is clinically evident

Your healthcare provider orders your test kit through our online provider portal.

Your blood sample is collected through a simple blood draw using one of three convenient options: in-office collection (if offered by your provider), mobile phlebotomy, or an outpatient collection site.
*Blood collection options are based on provider preference and availability in your area.

Your sample is shipped to our CLIA-certified and CAP-accredited laboratory using the prepaid shipping materials included with your test kit.

Once your results are ready, both you and your healthcare provider will be notified. Your provider will review your results with you. Results are available within 7–10 business days.
Your healthcare provider orders your test kit through our online provider portal.
Your blood sample is collected through a simple blood draw using one of three convenient options: in-office collection (if offered by your provider), mobile phlebotomy, or an outpatient collection site.
*Blood collection options are based on provider preference and availability in your area.
Your sample is shipped to our CLIA-certified and CAP-accredited laboratory using the prepaid shipping materials included with your test kit.
Once your results are ready, both you and your healthcare provider will be notified. Your provider will review your results with you. Results are available within 7–10 business days.

Your healthcare provider orders your test kit through our online provider portal.

Your blood sample is collected through a simple blood draw using one of three convenient options: in-office collection (if offered by your provider), mobile phlebotomy, or an outpatient collection site.
*Blood collection options are based on provider preference and availability in your area.

Your sample is shipped to our CLIA-certified and CAP-accredited laboratory using the prepaid shipping materials included with your test kit.

Once your results are ready, both you and your healthcare provider will be notified. Your provider will review your results with you. Results are available within 7–10 business days.
This simple guide explains the testing process, what to expect, how your sample is collected, and when results are available.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
GFAP • UCH-L1 • S100β • NF-H
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
GFAP • UCH-L1 • S100β • NF-H
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Our team helps coordinate each step of the testing process, from scheduling your blood draw to delivering results to your healthcare provider.
Your information is protected through HIPAA-compliant processes designed to safeguard your privacy and security.
Flexible blood collection methods, including in-office, mobile, and outpatient phlebotomy blood collection, help make your testing process simple and accessible.
CAP accreditation, CLIA certification, and validated testing methodologies reflect our dedication to quality, accuracy, and the delivery of reliable neurodiagnostic information.
